Circulation Research, Vol 63, 1070-1079, Copyright © 1988 by American Heart Association

ARTICLES

Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion

PJ Simpson, JC Fantone, JK Mickelson, KP Gallagher and BR Lucchesi
Department of Pharmacology, University of Michigan Medical School, Ann Arbor.

The cardio-protective effects of neutrophil depletion or inhibition of neutrophil activation early in the course of myocardial reperfusion has been established. Whether these treatments would be effective during extended periods of reperfusion has not been ascertained. Open-chest anesthetized dogs were subjected to left circumflex artery (LCX) occlusion for 90 minutes followed by 72 hours of reperfusion. Dogs were randomized into one of four groups: 1) control; 2) Ilo-2 (iloprost 100 ng/kg/min administered via the left atrium beginning 10 minutes after LCX occlusion and continuing 2 hours into reperfusion); 3) Ilo-48 (iloprost 100 ng/kg/min administered as above until 1 hour after reperfusion then 25 ng/kg/min for 48 hours of reperfusion; or 4) antibody (neutrophil antibody administered before occlusion and 1/2 hourly for 2 hours of reperfusion and then every 24 hours). Myocardial infarct size, as a percentage of the area at risk assessed after 72 hours of reperfusion, was significantly smaller in the antibody-treated group (32.1 +/- 5.0% mean +/- SEM) or Ilo-48 (22.6 +/- 4.0%) treatment group compared with control (48.7 +/- 5.6%) or Ilo-2 (57.6 +/- 5.2%) groups. Regional myocardial blood flow studies demonstrated that all groups developed similar degrees of ischemia. The iloprost-treated groups had lower mean arterial blood pressures during occlusion and reperfusion than groups 1 and 4 (p less than 0.05). Circulating neutrophil counts were increased in groups 1 and 2 at 24 and 48 hours after reperfusion compared to groups 3 and 4 (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Sezer, I. Okcular, T. Goren, H. Oflaz, Y. Nisanci, B. Umman, F. Mercanoglu, A. K Bilge, M. Meric, and S. Umman Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention Heart, March 1, 2007; 93(3): 313 - 318. [Abstract] [Full Text] [PDF]

				D. Li, V. Williams, L. Liu, H. Chen, T. Sawamura, T. Antakli, and J. L. Mehta LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1795 - H1801. [Abstract] [Full Text] [PDF]

				Z.-Q. Zhao and J. Vinten-Johansen Myocardial apoptosis and ischemic preconditioning Cardiovasc Res, August 15, 2002; 55(3): 438 - 455. [Abstract] [Full Text] [PDF]

				T O'malley, C.A Ludlam, R.A Riemermsa, and K.A.A Fox Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1). Potential risk factor for the acute coronary syndromes Eur. Heart J., July 2, 2001; 22(14): 1226 - 1234. [Abstract] [PDF]

				S. A. Briaud, Z.-M. Ding, L. H. Michael, M. L. Entman, S. Daniel, and C. M. Ballantyne Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H60 - H67. [Abstract] [Full Text] [PDF]

				C. Kupatt, H. Habazettl, P. Hanusch, R. Wichels, D. Hahnel, B. F. Becker, and P. Boekstegers c7E3Fab Reduces Postischemic Leukocyte-Thrombocyte Interaction Mediated by Fibrinogen : Implications for Myocardial Reperfusion Injury Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2226 - 2232. [Abstract] [Full Text] [PDF]

				J. M Budde, D. A Velez, Z.-Q. Zhao, K. L Clark, C. D Morris, S. Muraki, R. A Guyton, and J. Vinten-Johansen Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion Cardiovasc Res, August 1, 2000; 47(2): 294 - 305. [Abstract] [Full Text] [PDF]

				M. Arai, Y. Masui, P. Goldschmidt-Clermont, A. DiPaula, C. Siu, T. Kondo, and L. C. Becker P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion J. Am. Coll. Cardiol., July 1, 1999; 34(1): 280 - 288. [Abstract] [Full Text] [PDF]

				B. Y. Poon, C. A. Ward, W. R. Giles, and P. Kubes Emigrated Neutrophils Regulate Ventricular Contractility via {alpha}4 Integrin Circ. Res., June 11, 1999; 84(11): 1245 - 1251. [Abstract] [Full Text] [PDF]

				C. Kupatt, H. Habazettl, A. Goedecke, D. A. Wolf, S. Zahler, P. Boekstegers, R. A. Kelly, and B. F. Becker Tumor Necrosis Factor-{alpha} Contributes to Ischemia- and Reperfusion-Induced Endothelial Activation in Isolated Hearts Circ. Res., March 5, 1999; 84(4): 392 - 400. [Abstract] [Full Text] [PDF]

				P. V. Petrik, B. Braithwaite, W. S. Moore, H. A. Gelabert, and W. Quinones-Baldrich Pentoxifylline Improves Skeletal Muscle Recovery After Acute Ischemic and Reperfusion Injury Vascular and Endovascular Surgery, January 1, 1998; 32(1): 5 - 12. [Abstract] [PDF]

				K. S. Kilgore, E. J. Tanhehco, J. L. Park, K. B. Naylor, M. B. Anderson, and B. R. Lucchesi Reduction of Myocardial Infarct Size In Vivo by Carbohydrate-Based Glycomimetics J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 427 - 435. [Abstract] [Full Text]

				G. Ambrosio, I. Tritto, and P. Golino Reactive oxygen metabolites and arterial thrombosis Cardiovasc Res, June 1, 1997; 34(3): 445 - 452. [Abstract] [Full Text] [PDF]

				E. A. Gill, Y. Kong, and L. D. Horwitz An Oligosaccharide Sialyl-Lewisx Analogue Does Not Reduce Myocardial Infarct Size After Ischemia and Reperfusion in Dogs Circulation, August 1, 1996; 94(3): 542 - 546. [Abstract] [Full Text]

				K. S. Kilgore, J. L. Park, L. Chi, J. H. Musser, V. Date, S. Abbas, and B. R. Lucchesi Reduction of Myocardial Infarct Size in the Rabbit by a Carbohydrate Analog of Sialyl Lewisx Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1996; 1(1): 49 - 56. [Abstract] [PDF]